Supernus, Inc. (SUPN)
NASDAQ · Manufacturing · Pharmaceutical preparations
SUPN price, last 12 months
Key stats
- Previous close
- $28.96
- Open
- $29.11
- Day range
- $28.32 – $29.37
- 52-week range
- $25.92 – $59.68
- Volume
- 2.4M
- Avg volume (20 days)
- 3.3M
- Market cap
- $6.2B
Performance
Technicals and fundamentals
About Supernus, Inc.
Supernus Inc is a diversified biopharmaceutical company focused on developing and commercializing treatments for patients living with central nervous system (CNS) diseases. The company's commercial portfolio includes approved treatments designed to support individuals navigating opioid use disorder (OUD), attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) for those receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $6.2B